Design and evaluation of dihydroisoquinolines as potent and orally bioavailable human cytomegalovirus inhibitors

被引：14
|
作者：
Chan, L [1 ]
Stefanac, T [1 ]
Turcotte, N [1 ]
Hu, ZH [1 ]
Chen, YM [1 ]
Bédard, J [1 ]
May, S [1 ]
Jin, HL [1 ]
机构：
[1] Biochem Pharma Inc, Laval, PQ H7V 4A7, Canada
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2000年 / 10卷 / 13期
关键词：
D O I：
10.1016/S0960-894X(00)00265-1
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Following the identification of first pass metabolism issues with our recently described anti-HCMV compounds, the naphthyridines and isoquinolines, we have designed a class of novel metabolically stable and orally bioavailable anti-HCMV agents, the dihydroisoquinolines. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：1477 / 1480
页数：4
相关论文
共 50 条
  • [21] Identification of potent, orally bioavailable nonnucleoside HCV RNA polymerase inhibitors
    Dragovich, Peter S.
    Brooks, Jennifer
    Bartkowski, Darian M.
    Blazel, Julie K.
    Dao, Kimkim
    Ellis, David A.
    Gobbi, Alberto
    Kamran, Ruhi
    Kim, Sun Hee
    LeBrun, Laurie A.
    Li, Lian-Sheng
    Murphy, Douglas E.
    Nolan, Thomas G.
    Norris, Daniel A.
    Patel, Rupal
    Ruebsam, Frank
    Sergeeva, Maria V.
    Shah, Amit M.
    Showalter, Richard E.
    Stankovic, Nebojsa
    Sun, Zhongxiang
    Tran, Chinh V.
    Tran, Martin T.
    Tsan, Mei
    Webber, Stephen E.
    Xiang, Alan X.
    Zhao, Jingjing
    Kirkovsky, Leo
    Zhou, Yuefen
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [22] Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors
    Garton, Neil S.
    Barker, Michael D.
    Davis, Rob P.
    Douault, Clement
    Hooper-Greenhill, Edward
    Jones, Emma
    Lewis, Huw D.
    Liddle, John
    Lugo, Dave
    McCleary, Scott
    Preston, Alex G. S.
    Ramirez-Molina, Cesar
    Neu, Margarete
    Shipley, Tracy J.
    Somers, Don O.
    Watson, Robert J.
    Wilson, David M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (19) : 4606 - 4612
  • [23] Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase
    Augeri, DJ
    Janowick, D
    Kalvin, D
    Sullivan, G
    Larsen, J
    Dickman, D
    Ding, H
    Cohen, J
    Lee, J
    Warner, R
    Kovar, P
    Cherian, S
    Saeed, B
    Zhang, HC
    Tahir, S
    Ng, SC
    Sham, H
    Rosenberg, SH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (08) : 1069 - 1074
  • [24] Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors
    Velcicky, Juraj
    Janser, Philipp
    Gommermann, Nina
    Brenneisen, Silke
    Ilic, Slavica
    Vangrevelinghe, Eric
    Stiefl, Nikolaus
    Boettcher, Andreas
    Arnold, Christelle
    Malinverni, Claire
    Dawson, Janet
    Murgasova, Renata
    Desrayaud, Sandrine
    Beltz, Karen
    Hinniger, Alexandra
    Dekker, Carien
    Farady, Christopher J.
    Mackay, Angela
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (02) : 1544 - 1562
  • [25] Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors
    Hu, Dennis X.
    Patel, Snahel
    Chen, Huifen
    Wang, Shumei
    Staben, Steven T.
    Dimitrova, Yoana N.
    Wallweber, Heidi Ackerly
    Lee, Joanna Y.
    Chan, Grace Ka Yan
    Sneeringer, Christopher J.
    Prangley, Madeleine S.
    Moffat, John G.
    Wu, Kai C.
    Schutt, Leah K.
    Salphati, Laurent
    Pang, Jodie
    McNamara, Erin
    Huang, Haochu
    Chen, Yong
    Wang, Yunli
    Zhao, Wensheng
    Lim, Junghyun
    Murthy, Aditya
    Siu, Michael
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, : 11500 - 11512
  • [26] Structure-based design and discovery of orally bioavailable potent nonbenzamidine factor Xa inhibitors.
    Lam, PYS
    Li, RH
    Clark, CG
    Pinto, DJ
    Alexander, RS
    Rossi, KA
    Knabb, RM
    Wong, PC
    Aungst, BJ
    Bai, SA
    Wright, MR
    Wexler, RR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U31 - U31
  • [27] Identification of Monosaccharide Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Human and Mouse Galectin-3
    Liu, Chunjian
    Jalagam, Prasada Rao
    Feng, Jianxin
    Wang, Wei
    Raja, Thiruvenkadam
    Sura, Mallikarjuna Reddy
    Manepalli, Raju K. V. L. P.
    Aliphedi, Bheema Reddy
    Medavarapu, Santosh
    Muthalagu, Vetrichelvan
    Natesan, Ramesh
    Gupta, Anuradha
    Beno, Brett
    Panda, Manoranjan
    Ghosh, Kaushik
    Shukla, Jinal Kaushikkumar
    Sale, Harinath
    Haldar, Priyanka
    Kalidindi, Narasimharaju
    Shah, Devang
    Patel, Dipal
    Mathur, Arvind
    Ellsworth, Bruce A.
    Cheng, Dong
    Regueiro-Ren, Alicia
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (16) : 11084 - 11099
  • [28] Discovery of potent, orally bioavailable small-molecule inhibitors of the human CCR2 receptor
    Doyon, Julien
    Coesemans, Erwin
    Boeckx, Staf
    Buntinx, Mieke
    Hermans, Bart
    Van Wauwe, Jean P.
    Gilissen, Ron A. H. J.
    De Groot, Alex H. J.
    Corens, David
    Van Lommen, Guy
    CHEMMEDCHEM, 2008, 3 (04) : 660 - 669
  • [29] Discovery of Orally Bioavailable Ligand Efficient Quinazolindiones as Potent and Selective Tankyrases Inhibitors
    Qin, Donghui
    Lin, Xiaojuan
    Liu, Zhi
    Chen, Yan
    Zhang, Zhiliu
    Wu, Chengde
    Liu, Linlin
    Pan, Yan
    Laquerre, Sylvie
    Emery, John
    Fergusson, Jeff
    Roland, Kimberly
    Keenan, Rick
    Oliff, Allen
    Kumar, Sanjay
    Cheung, Mui
    Su, Dai-Shi
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (06): : 1005 - 1010
  • [30] Phthalazinone Pyrazoles as Potent, Selective, and Orally Bioavailable Inhibitors of Aurora-A Kinase
    Prime, Michael E.
    Courtney, Stephen M.
    Brookfield, Frederick A.
    Marston, Richard W.
    Walker, Victoria
    Warne, Justin
    Boyd, Andrew E.
    Kairies, Norman A.
    von der Saal, Wolfgang
    Limberg, Anja
    Georges, Guy
    Engh, Richard A.
    Goller, Bernhard
    Rueger, Petra
    Rueth, Matthias
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (01) : 312 - 319
12345